- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03944967
Postoperative Remote Monitoring of Vital Signs in Older Cardiac Surgery Patients (AGEAWARE)
A significant number of elderly patients experience a complication after cardiac surgery. This study aims to determine if postoperative remote monitoring of vital signs can be used to identify medicatie risk factors for vital sign deterioration in older cardiac surgery patients.
- Single center pilot study.
- 100 older patients undergoing cardiac surgery.
- Continuous remote monitoring of vital signs after ICU discharge
- Main study endpoint is vital sign deterioration.
Study Overview
Status
Conditions
Detailed Description
Cardiac surgery in elderly patients aims to improve functional capacity and overall survival but may also precipitate major morbidity and mortality. Despite major improvements in the safety of anesthesia and surgery a significant number of elderly patients experience a complication after cardiac surgery.
To determine if postoperative remote monitoring of vital signs can be used to identify medication risk factors for vital sign deterioration in older cardiac surgery patients..
- Single center pilot study.
- 100 older patients undergoing cardiac surgery.
- Continuous remote monitoring of vital signs starts after ICU discharge
- PR, RR and SpO2 will be continuously monitored in all patients.
- Patients and healthcare personnel are blinded for monitoring results.
- Main study endpoint is vital sign deterioration.
The study population includes 100 patients ≥70 years undergoing elective cardiac surgery.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Utrecht
-
Nieuwegein, Utrecht, Netherlands, 3435 CM
- St Antonius hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- ≥70 years undergoing elective cardiac surgery.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hypoxemia
Time Frame: Three consecutive days after ICU discharge
|
Duration of sPO2 <80%, <85%, <90% and <95% in minutes per hour
|
Three consecutive days after ICU discharge
|
|
Respiratory deterioration
Time Frame: Three consecutive days after ICU discharge
|
Duration of respiratory rate <10 min-1, >20 min-1, >25 min-1, >30 min-1 in minutes per hour
|
Three consecutive days after ICU discharge
|
|
Arrythmia
Time Frame: Three consecutive days after ICU discharge
|
Duration of pulse rate <50 min-1, >100 min-1, >110 min-1, >120 min-1 in minutes per hour
|
Three consecutive days after ICU discharge
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL68944.100.19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.